BeStock  

Adaptive Biotechnologies ADPT

US equityMarket cap rank #2124Diagnostics & Research
$27.93 −$0.12 (-0.43%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.89 -0.14%
Open$27.43
Prev close$28.05
Day range$27.15 – $28.23
Volume2.48M
Market cap$4.52B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$33.43+19.7% vs. price
  • Buy 88%
  • Hold 13%
Low $27.00Now $27.93Avg $33.43High $35.00

Recent rating changes

The last 20 actions on file set price targets from $25.00 to $35.00, averaging $31.03.

DateFirmRatingTarget
10 Nov 2026 Piper Sandler BUY $35.00
10 Nov 2026 Guggenheim BUY $34.00
9 Nov 2026 J.P. Morgan BUY $35.00
5 Nov 2026 TD Cowen BUY $34.00
5 Nov 2026 Piper Sandler BUY $27.50
5 Nov 2026 BTIG BUY $34.00
14 Oct 2026 J.P. Morgan BUY $30.00
13 Oct 2026 TD Cowen BUY $32.00
13 Oct 2026 Morgan Stanley HOLD $27.00
9 Oct 2026 Morgan Stanley HOLD $27.00
1 Oct 2026 Guggenheim BUY $32.00
29 Sep 2026 Goldman Sachs BUY $35.00
22 Sep 2026 BTIG BUY $34.00
21 Sep 2026 BTIG BUY $34.00
17 Sep 2026 Craig-Hallum BUY –
24 Aug 2026 Piper Sandler BUY $27.50
4 Aug 2026 Piper Sandler BUY $27.50
30 Jul 2026 TD Cowen BUY $28.00
30 Jul 2026 William Blair BUY –
30 Jul 2026 BTIG BUY $25.00

Discussion

No comments yet — be the first to weigh in on ADPT.

Sign in to join the discussion.

Scroll to Top